Author: Alan Brochstein, CFA
The SEC has filed fraud charges related to a cannabis penny stock for the second time in less than a week. Last week, it announced a civil case against...
In 2015, Health Canada issued just five new cannabis cultivation licenses during the entire year. Last week, it issued just as many, bringing the year-to-date total to 13 and...
After the close on Friday, the SEC announced that it has filed suit against Michael Mona, Jr., CEO of CV Sciences (OTC: CVSI) and the company, which was formerly...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF) added three names to its portfolio today as it scaled back several positions. The ETF had shared its top holdings...
In what appears to be one of the most successful cannabis industry investments to date, MedMen Opportunity Fund achieved realized and unrealized gains of about C$33.5mm on a C$10mm investment...
CannTrust Holdings, the parent of Canadian licensed producer CannTrust, has filed a preliminary prospectus detailing its offering of 12.5841mm Special Warrants at $2 per warrant, for $25.2mm in gross...
The Canadian cannabis sector’s largest IPO to date is a dud. The $100mm MedReleaf (TSX: LEAF) IPO was priced at $9.50 but opened for trading at $7.51 before trading...
As the U.S. cannabis industry has evolved over the past few years, so has the market for publicly-traded cannabis stocks. In 2014, very few publicly-traded companies were reporting substantial...
Laidlaw & Company, which underwrote the recent IPO for Therapix Biosciences (NASDAQ: TRPX), has initiated research coverage of the company, giving it a “Buy” rating and suggesting a price...
Berkeley-based cannabis testing lab Steep Hill extended its presence in California and also entered a new market, the Southeast, opening a full-service lab in Arkansas, which approved medical cannabis...
After initially filing its preliminary prospectus in April, ACMPR licensed producer MedReleaf (TSX: LEAF) has filed the final prospectus for its $100.7mm initial public offering and secondary offering, selling shares...
First Trust Files Prospectus for FT 6766 Medical Cannabis Portfolio Series Illinois-based fund manager First Trust, which manages over $100 billion in aggregate across a range of retail and...
Innovative Industrial Properties (NYSE: IIPR), which also announced the closing of a cultivation and processing facility in Maryland, has declared its initial dividend. The company will pay $0.15 per share on July...
The National Cannabis Industry Association (NCIA) held its annual elections to fill 11 of the 22 board seats. 33 candidates ran for election. All eight incumbents were reelected to...
Health Canada has updated its website, indicating that it has awarded the 44th ACMPR license to Ontario-based First Access Medical, which is owned by Beleave, Inc. (CSE: BE) (OTC:...
Montel Williams, a long-time medical cannabis advocate who has used it to help manage his Multiple Sclerosis since 2000, has created a company that is trying to address a...
BNN hosted the CFOs of Canopy Growth (TSX: WEED) (OTC: TWMJF), its partially owned subsidiary, Canopy Health Innovations, and Emblem (TSXV: EMC) (OTC: EMMBF) on Money Talk on May...
General Cannabis (OTC: CANN) is one of the 26 cannabis-related companies I follow most closely at 420 Investor as part of my Focus List, and I continue to be cautious on...
The cannabis industry continues to attract new entrants every day, with many starting their own businesses and others joining established ones. Just yesterday, for example, KIND Financial announced that...
A current marketing campaign by start-up media publisher Civilized strikes us as remarkably irresponsible. The company, which recently raised $1mm in a Series A round, appears to be violating Canadian...
Canadian LP Aphria (TSX: APH) (OTC: APHQF), which purchased a 6mm share stake in Canabo Medical Corp (TSXV: CMM) (OTC: CAMDF) at $1.40 per share in December, has sharply reduced...
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
After filing its preliminary prospectus for its pending IPO last month, MedReleaf revised it on May 9th, sharing a lot more information. The Canadian cannabis deal, underwritten by GMP...
Exclusive Interview with Cannabis Wheaton CEO Chuck Rifici With Canada potentially facing a substantial undersupply of cannabis product next year as the market becomes legal for adults, licensed producers...
Following the success of the first cannabis-focused exchange-traded fund (ETF), the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), which has quickly exceeded C$120mm in assets since...
